Literature DB >> 7763910

Sub-micrometer-sized biodegradable particles of poly(L-lactic acid) via the gas antisolvent spray precipitation process.

T W Randolph1, A D Randolph, M Mebes, S Yeung.   

Abstract

Sub-micrometer-sized particles of poly(L-lactic acid) may be formed by using near-critical or supercritical carbon dioxide as an antisolvent to precipitate poly(L-lactic acid) from droplets of methylene chloride solution sprayed into a carbon dioxide continuous phase. Particle sizes may be controlled by varying the density of the carbon dioxide; at constant temperature in the supercritical region, higher carbon dioxide densities yield larger particles. Two methods (one batch and one continuous) for introducing the poly(L-lactic acid) solutions into carbon dioxide are demonstrated. Although the two methods use very different mechanisms for forming the droplets, similar particle sizes are observed as a function of carbon dioxide density. We suggest that mass transport, rather than jet breakup and hydrodynamics, controls particle sizes in the near-critical and supercritical regions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7763910     DOI: 10.1021/bp00022a010

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  12 in total

1.  Bacterial inactivation by using near- and supercritical carbon dioxide.

Authors:  A K Dillow; F Dehghani; J S Hrkach; N R Foster; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

Review 2.  Phase behavioral effects on particle formation processes using supercritical fluids.

Authors:  S Palakodaty; P York
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

3.  Long-term and high-temperature storage of supercritically-processed microparticulate protein powders.

Authors:  M A Winters; P G Debenedetti; J Carey; H G Sparks; S U Sane; T M Przybycien
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

4.  Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres.

Authors:  J L Cleland; A J Jones
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

5.  Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray-freezing into liquid with atmospheric freeze-drying.

Authors:  True L Rogers; Andrew C Nelsen; Marazban Sarkari; Timothy J Young; Keith P Johnston; Robert O Williams
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

6.  Process variable implications for residual solvent removal and polymer morphology in the formation of gentamycin-loaded poly (L-lactide) microparticles.

Authors:  R F Falk; T W Randolph
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

7.  Formation of inhalable rifampicin-poly(L-lactide) microparticles by supercritical anti-solvent process.

Authors:  Vipaluk Patomchaiviwat; Ornlaksana Paeratakul; Poj Kulvanich
Journal:  AAPS PharmSciTech       Date:  2008-11-07       Impact factor: 3.246

8.  Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology.

Authors:  Todd M Martin; Nagesh Bandi; Ryan Shulz; Christopher B Roberts; Uday B Kompella
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

9.  Supercritical phase inversion of starch-poly(epsilon-caprolactone) for tissue engineering applications.

Authors:  Ana Rita C Duarte; João F Mano; Rui L Reis
Journal:  J Mater Sci Mater Med       Date:  2009-10-20       Impact factor: 3.896

10.  Study of poly(L-lactide) microparticles based on supercritical CO2.

Authors:  Ai-Zheng Chen; Xi-Ming Pu; Yun-Qing Kang; Li Liao; Ya-Dong Yao; Guang-Fu Yin
Journal:  J Mater Sci Mater Med       Date:  2007-06-14       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.